Works matching DE "POSITRON emission tomography"

Results: 5000
    1
    2

    Serendipitous discovery of mediastinal tuberculous lymphadenitis in a patient on maintenance hemodialysis.

    Published in:
    Hemodialysis International, 2011, v. 15, n. 4, p. 583, doi. 10.1111/j.1542-4758.2011.00576.x
    By:
    • Yadla, Manjusha;
    • Sainaresh, Vellanki Venkata;
    • Sriramnaveen, Parvithina;
    • Kishore, Krishna;
    • Reddy, Sandeep;
    • Sridhar, Anappindi Venkata Satya Surya Naga;
    • Phanindra, Bommidi Venkata;
    • Bodagala, Vijayalakshmi;
    • Amancharla Yadagiri, Lakshmi;
    • Kalawat, Tek Chand;
    • Sivakumar, Vishnubhotla
    Publication type:
    Article
    3
    4
    5
    6
    7
    8

    Positron-emission tomography in imaging and staging prostate cancer.

    Published in:
    Cancer Biomarkers, 2008, v. 4, n. 4/5, p. 277, doi. 10.3233/CBM-2008-44-509
    By:
    • Farsad, M.;
    • Schiavina, R.;
    • Franceschelli, A.;
    • Sanguedolce, F.;
    • Castellucci, P.;
    • Bertaccini, A.;
    • Brunocilla, E.;
    • Manferrari, F.;
    • Concetti, S.;
    • Garofalo, M.;
    • Rocca, C.;
    • Borghesi, M.;
    • Franchi, R.;
    • Fanti, S.;
    • Nanni, C.;
    • Martorana, G.
    Publication type:
    Article
    9
    10
    11
    12
    13
    14

    Metabolic connectivity of freezing in Parkinson's disease.

    Published in:
    Journal of Parkinson's Disease, 2025, v. 15, n. 1, p. 154, doi. 10.1177/1877718X241305713
    By:
    • Tard, Céline;
    • Delval, Arnaud;
    • Defebvre, Luc;
    • Lenfant, Pierre;
    • Devos, David;
    • Moreau, Caroline;
    • Betrouni, Nacim
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30

    The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson's Disease.

    Published in:
    Journal of Parkinson's Disease, 2019, v. 9, n. 3, p. 553, doi. 10.3233/JPD-191648
    By:
    • Stephenson, Diane;
    • Hill, Derek;
    • Cedarbaum, Jesse M.;
    • Tome, Maria;
    • Vamvakas, Spiros;
    • Romero, Klaus;
    • Conrado, Daniela J.;
    • Dexter, David T.;
    • Seibyl, John;
    • Jennings, Danna;
    • Nicholas, Timothy;
    • Matthews, Dawn;
    • Xie, Zhiyong;
    • Imam, Syed;
    • Maguire, Paul;
    • Russell, David;
    • Gordon, Mark Forrest;
    • Stebbins, Glenn T.;
    • Somer, Ed;
    • Gallagher, Jill
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43

    Single‐Subject Network Analysis of FDOPA PET in Parkinson's Disease and Psychosis Spectrum.

    Published in:
    Human Brain Mapping, 2025, v. 46, n. 8, p. 1, doi. 10.1002/hbm.70253
    By:
    • Severino, Mario;
    • Schubert, Julia J.;
    • Nordio, Giovanna;
    • Giacomel, Alessio;
    • Easmin, Rubaida;
    • Lao‐Kaim, Nick P.;
    • Selvaggi, Pierluigi;
    • Xu, Zhilei;
    • Pereira, Joana B.;
    • Jauhar, Sameer;
    • Piccini, Paola;
    • Howes, Oliver;
    • Turkheimer, Federico;
    • Veronese, Mattia;
    • Angelescu, Ilinca;
    • Bloomfield, Micheal;
    • Bonoldi, Ilaria;
    • Borgan, Faith;
    • Dahoun, Tarik;
    • Enrico, D'Ambrosio
    Publication type:
    Article
    44

    [<sup>18</sup>F]FET PET-Guided management of pseudoprogression in glioblastoma (FET POPPING): the study protocol for a diagnostic randomized clinical trial.

    Published in:
    Trials, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s13063-025-08921-8
    By:
    • Ruijters, V.J.;
    • Snijders, T.J.;
    • van der Pol, J.A.J.;
    • van de Giessen, E.M.;
    • Niers, J.M.;
    • Broen, M.P.G.;
    • Anten, M.M.;
    • van Zanten, S.E.M. Veldhuijzen;
    • Geurts, M.;
    • Arens, A.I.J.;
    • Henssen, D.J.H.A.;
    • Gijtenbeek, J.M.;
    • van der Meulen, M.;
    • Sijben, A.E.J.;
    • Ghariq, E.;
    • Vos, M.J.;
    • Tim, J.;
    • Bosma, I.B.;
    • Stormezand, G.N.;
    • Frederix, G.W.J.
    Publication type:
    Article
    45
    46
    47
    48

    The utility of <sup>68</sup>Ga-DOTATATE and <sup>18</sup>F-FDG PET/CT in predicting the response to tyrosine kinase inhibitors in patients with advanced medullary thyroid cancer.

    Published in:
    Thyroid Research, 2025, v. 18, n. 1, p. 1, doi. 10.1186/s13044-025-00250-x
    By:
    • Jager, Eline C.;
    • McNeil, James;
    • Papachristos, Alexander J.;
    • Sywak, Mark;
    • Sidhu, Stan B.;
    • Siddall, Rhonda;
    • Hoang, Jeremy;
    • Schembri, Geoffrey P.;
    • Tsang, Venessa H. M.;
    • Wijewardene, Ayanthi;
    • Tacon, Lyndal;
    • Robinson, Bruce;
    • Clifton-Bligh, Roderick J.;
    • Bullock, Martyn;
    • Brouwers, Adrienne H.;
    • Links, Thera P.;
    • Kruijff, Schelto;
    • Glover, Anthony R.;
    • Gild, Matti L.
    Publication type:
    Article
    49
    50